StockData
Spero Therapeutics, Inc. logo

Spero Therapeutics, Inc. (SPRO) stock

SPRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3045% below fair value
$0.90−0.05 (-4.77%)

Close on Nov 17, 2026Market cap $52.49MP/E 22.5Yield –

Spero Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Spero Therapeutics's market cap was $59.31M on Nov 11, 2026, against $135.15M a year earlier. Over the last 5 years it ranged from $23.98M to $515.85M, with a median of $77.64M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$59.31M-54.8%
2025Dec 31, 2025$131.21M+134.5%
2024Dec 31, 2024$55.94M-28.2%
2023Dec 29, 2023$77.91M+5.1%
2022Dec 30, 2022$74.14M-85.6%
2021Dec 31, 2021$515.85M+2.4%
2020Dec 31, 2020$503.56M+180.6%
2019Dec 31, 2019$179.45M+60.5%
2018Dec 31, 2018$111.82M+2738.5%
2017Dec 29, 2017$3.94M–

More Spero Therapeutics figures

See a number that looks wrong?